Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States
- PMID: 19109115
- PMCID: PMC2702513
- DOI: 10.1001/jama.2008.892
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States
Abstract
Context: Despite concerns about drug safety, current information on older adults' use of prescription and over-the-counter medications and dietary supplements is limited.
Objective: To estimate the prevalence and patterns of medication use among older adults (including concurrent use), and potential major drug-drug interactions.
Design, setting, and participants: Three thousand five community-residing individuals, aged 57 through 85 years, were drawn from a cross-sectional, nationally representative probability sample of the United States. In-home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over-the-counter, and dietary supplements used "on a regular schedule, like every day or every week." Concurrent use was defined as the regular use of at least 2 medications.
Main outcome measure: Population estimates of the prevalence of medication use, concurrent use, and potential major drug-drug interactions, stratified by age group and gender.
Results: The unweighted survey response rate was 74.8% (weighted response rate, 75.5%). Eighty-one percent (95% confidence interval [CI], 79.4%-83.5%) used at least 1 prescription medication, 42% (95% CI, 39.7%-44.8%) used at least 1 over-the-counter medication, and 49% (95% CI, 46.2%-52.7%) used a dietary supplement. Twenty-nine percent (95% CI, 26.6%-30.6%) used at least 5 prescription medications concurrently; this was highest among men (37.1%; 95% CI, 31.7%-42.4%) and women (36.0%; 95% CI, 30.2%-41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over-the-counter medications was 46% (95% CI, 43.4%-49.1%) and concurrent use of dietary supplements was 52% (95% CI, 48.8%-55.5%). Overall, 4% of individuals were potentially at risk of having a major drug-drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group (10%; 95% CI, 6.4%-13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified.
Conclusions: In this sample of community-dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug-drug interaction.
Figures
Similar articles
-
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.JAMA Intern Med. 2016 Apr;176(4):473-82. doi: 10.1001/jamainternmed.2015.8581. JAMA Intern Med. 2016. PMID: 26998708 Free PMC article.
-
Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.Drugs Aging. 2009;26(5):423-36. doi: 10.2165/00002512-200926050-00006. Drugs Aging. 2009. PMID: 19552494
-
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.JAMA. 2002 Jan 16;287(3):337-44. doi: 10.1001/jama.287.3.337. JAMA. 2002. PMID: 11790213
-
Concomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness.Maturitas. 2011 Mar;68(3):251-5. doi: 10.1016/j.maturitas.2010.11.017. Epub 2010 Dec 17. Maturitas. 2011. PMID: 21168291 Free PMC article. Review.
-
Utilization and Safety of Common Over-the-Counter Dietary/Nutritional Supplements, Herbal Agents, and Homeopathic Compounds for Disease Prevention.Med Clin North Am. 2016 Sep;100(5):1089-99. doi: 10.1016/j.mcna.2016.04.017. Med Clin North Am. 2016. PMID: 27542428 Review.
Cited by
-
The High Prevalence and Complexity of Over-the-Counter Medication Misuse in Older Adults.Innov Aging. 2024 Sep 10;8(10):igae083. doi: 10.1093/geroni/igae083. eCollection 2024. Innov Aging. 2024. PMID: 39464723 Free PMC article.
-
Magnitude of multiple drug use and determinants of vulnerability among chronic kidney disease inpatients in Ethiopia: a multi-center study.BMC Nephrol. 2024 Oct 7;25(1):332. doi: 10.1186/s12882-024-03773-x. BMC Nephrol. 2024. PMID: 39375593 Free PMC article.
-
Health Risk Assessment of Toxic Metal(loids) Consumed Through Plant-Based Anti-diabetic Therapeutics Collected in the Northern Divisional City of Rajshahi, Bangladesh.Biol Trace Elem Res. 2024 Aug 12. doi: 10.1007/s12011-024-04338-7. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 39129053
-
Patterns of self-medication and intention to seek pharmacist guidance among older adults during the COVID-19 pandemic in Macao: a cross-sectional study.BMC Public Health. 2024 Jul 31;24(1):2066. doi: 10.1186/s12889-024-19453-2. BMC Public Health. 2024. PMID: 39085834 Free PMC article.
-
Prevention of Chronic Kidney Disease and Its Complications in Older Adults.Drugs Aging. 2024 Jul;41(7):565-576. doi: 10.1007/s40266-024-01128-7. Epub 2024 Jun 26. Drugs Aging. 2024. PMID: 38926293 Review.
References
-
- Catlin A, Cowan C, Hartman M, Heffler S National Health Expenditure Accounts Team. National health spending in 2006: a year of change for prescription drugs. Health Aff (Millwood) 2008;27(1):14–29. - PubMed
-
- Hanlon JT, Fillenbaum GG, Ruby CM, Gray S, Bohannon A. Epidemiology of over-the-counter drug use in community dwelling elderly—United States perspective. Drugs Aging. 2001;18(2):123–131. - PubMed
-
- Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol. 2004;160(4):339–349. - PubMed
-
- Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–1116. - PubMed
-
- Institute of Medicine (IOM) The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: IOM; 2006.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
